Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer November 24, 2015December 14, 2022 Arthur N. Brodsky, PhD
Second Antibody FDA-Approved Against Multiple Myeloma December 1, 2015December 14, 2022 Arthur N. Brodsky, PhD
FDA Approval Expands Immunotherapy Options for Advanced Melanoma January 27, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Nivolumab (Opdivo) for Advanced Hodgkin Lymphoma Patients May 17, 2016December 14, 2022 Arthur N. Brodsky, PhD